Skip to main content

Table 2 Baseline infusion-related characteristics of study devices

From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial

Variable

3-Day Routine Change Group (n = 323),

n (%)

Clinically Indicated Change Group (n = 280),

n (%)

IV cannula gauge

  

   • 22

43 (13%)

46 (16%)

   • 20

241 (75%)

201 (72%)

   • 18

27 (12%)

30 (11%)

   • Other

2 (1%)

3 (1%)

Vein assessment

  

   • Good

143 (44.3%)

107 (38.2%)

   • Fair

160 (49.5%)

144 (51.4%)

   • Poor

20 (6.2%)

29 (10.4%)

Skin integrity

  

   • Good

138 (43%)

104 (37%)

   • Fair

178 (55%)

164 (59%)

   • Poor

7 (2%)

12 (4%)

Past history of phlebitis

2 (0.6%)

4 (1.4%)

Insertion site

  

   • Hand

206 (64%)

187 (67%)

   • Forearm

59 (18%)

49 (18%)

   • Cubital fossa

51 (16%)

38 (14%)

   • Other

7 (2%)

6 (2%)

Receiving infusate

241 (75%)

215 (77%)

pH of infusate - Mean (SD)

6.0 (0.5)

6.0 (0.4)

Receiving oral antibiotics

24 (7%)

24 (9%)

Receiving IV antibiotics

236 (73%)

176 (63%)

pH of IV antibiotics - Mean (SD)

6.9 (1.1)

6.9 (1.3)

Receiving other IV meds

190 (59%)

179 (64%)

pH of other IV meds - Mean (SD)

5.6 (2.6)

6.0 (2.8)

Wound drain

50 (16%)

40 (14%)

Urinary catheter

55 (17%)

41 (15%)

Other vascular device

26 (8%)

24 (9%)

Inserted by

  

   • Junior doctor

232 (72%)

207 (74%)

   • Registered Nurse

67 (21%)

57 (20%)

   • Senior doctor

24 (7%)

16 (6%)

Where inserted

  

   • Ward

216 (67%)

188 (67%)

   • Emergency department

74 (23%)

70 (25%)

   • Other

33 (10%)

22 (8%)

Current infection (site)

  

   • Respiratory

97 (30%)

49 (18%)

   • Urinary

24 (7%)

19 (7%)

   • Wound

16 (5%)

15 (5%)

   • Other

29 (9%)

37 (13%)

   • >1 site

5 (2%)

4 (1%)

   N/A (none)

152 (47%)

156 (56%)

Risk of phlebitis (Tagar scale)

  

   • Low

174 (54%)

144 (51%)

   • Medium

149 (46%)

136 (49%)

   • High

0

0